EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

Delayed Data
As of 4:00pm ET
 -0.57 / -5.89%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 60.00 and a low estimate of 24.00. The median estimate represents a +240.29% increase from the last price of 9.11.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in EyePoint Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.29%
Growthannually -18.52%


Growthquarterly 19.54%
Growthannually 24.00%
Key to the earnings and sales forecast charts.